Is SkinnyRx Legit? GLP-1 Platform Verification for 2026: Compounding Disclosures, FDA Context, Refund Terms, and a Step-by-Step Checklist for What to Verify Before You Enroll

An Independent Verification of Lean Rx, Inc.'s Telehealth Platform, 503A Pharmacy Model, Compounded Semaglutide and Tirzepatide Options From $199/Month, Subscription Cancellation Terms, and the FDA Regulatory Shifts Every Consumer Should Understand Before Choosing Any Compounded GLP-1 Program

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight management concerns should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. If you purchase through affiliate links in this article, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

SkinnyRx Platform Verification 2026: GLP-1 Compounding Disclosures, FDA Context, Refund Terms, and What Consumers Can Check Before Enrolling

You saw a SkinnyRx ad - probably on Instagram, Facebook, or TikTok. The pricing caught your attention. Maybe the transformation photos gave you a moment of hope. And then you did exactly what you should have done: you searched for it.

That search usually reflects the same concern many consumers share: verifying the platform, understanding the prescription process, reading the refund terms, and reviewing the regulatory disclosures before paying. That due diligence matters more than usual right now, because compounded GLP-1 medications are prescription drugs with real metabolic effects and real risks, and the telehealth platforms offering them operate in a regulatory environment that has shifted significantly over the past year.

Here is what the verification process looks like. SkinnyRx is operated by Lean Rx, Inc., a company registered in Sacramento, California. According to the company's own terms of use, Lean Rx, Inc. is not itself a healthcare provider. The platform connects patients with licensed medical providers who independently determine whether a prescription is appropriate. Medications are then prepared by compounding pharmacies that, according to SkinnyRx, are licensed by state boards of pharmacy and operate under applicable state and federal requirements.

The critical distinction - and this needs to be clear from the start: compounded medications are not FDA-approved as finished products. They are not individually evaluated by the FDA for safety, effectiveness, or quality before they are dispensed. SkinnyRx states this on its own website. Understanding what "compounded" means - and what it does not mean - is the foundation of any informed decision here.

This article walks through the platform structure, current FDA context, pricing, refund terms, and what you can and cannot verify independently. It is a verification article, not a recommendation.

If you are also researching specific aspects of the SkinnyRx platform, these additional analyses may be useful: a detailed examination of SkinnyRx's GLP-1 program, pricing, and FDA regulatory status, a comparison of injectable, sublingual, and tablet delivery formats, and an evaluation of compounded tirzepatide alternatives heading into 2026.

View current SkinnyRx program details

How SkinnyRx Works: The Three-Entity Structure

Like many telehealth platforms in this space, SkinnyRx operates through a three-entity structure. Understanding who does what helps you evaluate the platform and know exactly who is responsible for each part of your care.

Entity 1: SkinnyRx (Lean Rx, Inc.) - The Platform

According to the company's terms of use, Lean Rx, Inc. functions as the technology and service platform. Per those terms, the company provides the digital infrastructure, customer service coordination, and logistics that make the telehealth experience possible. SkinnyRx does not prescribe medications, does not make clinical decisions, and does not practice medicine. The company's own terms state: "Lean Rx, Inc. is not a healthcare provider."

SkinnyRx is registered at 2108 N ST STE N, Sacramento, CA 95816, and can be reached at [email protected] or 1-888-979-9580.

Entity 2: Licensed Medical Providers - Independent Clinicians

The prescribing decisions are made by independent licensed healthcare providers. SkinnyRx states that these providers are based in the United States, licensed, and board-certified, and that the platform offers care availability across all 50 states and Washington, D.C. These clinicians review patient intake information and conduct independent clinical evaluation to determine whether a GLP-1 prescription is medically appropriate. The platform cannot guarantee that any individual will receive a prescription - that determination rests entirely with the evaluating provider.

Entity 3: Compounding Pharmacies - State-Licensed Facilities

According to SkinnyRx, prescriptions may be filled by compounding pharmacies operating under applicable state and federal requirements. The company describes these as 503A pharmacies licensed by state boards of pharmacy.

Here is the important nuance: the pharmacies are described by the company as state-licensed compounding pharmacies operating under applicable legal and regulatory requirements, but the compounded medications they produce are not FDA-approved finished drugs. This is standard for the compounding industry and is not unique to SkinnyRx - but it is a distinction every consumer should understand before proceeding. Do not confuse a pharmacy being state-licensed with the medications it produces being FDA-approved. Those are two separate things.

Current FDA Context Around Compounded GLP-1 Medications

This is information that most competing pages in this space do not cover clearly, and it matters.

What compounded means in regulatory terms: Compounded drugs are not FDA-approved finished products. The FDA has stated this repeatedly and clearly. Compounded medications are prepared by pharmacies based on individual prescriptions, but they have not undergone the FDA's premarket review process for safety, effectiveness, or manufacturing quality that brand-name drugs go through.

Shortage status and enforcement timeline: The reason compounded GLP-1 medications became widely available through telehealth platforms was that both semaglutide and tirzepatide were on the FDA's drug shortage list - semaglutide since March 2022 and tirzepatide since December 2022. While a drug is on the shortage list, compounding pharmacies have broader legal authority to produce compounded versions.

That landscape has changed. FDA removed tirzepatide injection from the shortage list on October 2, 2024, later reevaluated that decision, and then confirmed in December 2024 that the shortage was resolved. The semaglutide shortage was resolved in February 2025 when the FDA removed it from the drug shortage list. With those shortages resolved, the FDA's temporary enforcement discretion periods for compounding have ended. Compounding pharmacies that wish to continue compounding these medications must now operate under the standard compounding rules - which generally restrict pharmacies from producing products that are "essentially copies" of commercially available FDA-approved drugs, with limited exceptions.

What this means for consumers: The regulatory framework under which compounded GLP-1 products are produced and distributed continues to evolve. Brand-name drug manufacturers have been pursuing legal actions related to compounded versions of their products. Consumers considering any compounded GLP-1 platform - not just SkinnyRx - should review the most current FDA information and understand that the availability and regulatory status of compounded formulations may change.

This is not a reason to panic, but it is a reason to stay informed. Consumers should review current FDA communications on compounded GLP-1 products before enrolling in any program.

This article does not make any determination about SkinnyRx's current compliance status. Only the company and its legal counsel can speak to how their operations have adapted to the current regulatory environment.

What SkinnyRx Offers: Medication Options and Pricing

According to the SkinnyRx website, the platform currently lists compounded semaglutide and compounded tirzepatide options in injectable, sublingual, and tablet formats. Here is the pricing as publicly listed on the site at the time of this publication:

Semaglutide Options:

  • Compounded Injectable Semaglutide (once-weekly injection): according to the company, as low as $199 per month

  • Compounded Sublingual Semaglutide (dissolved under the tongue daily): according to the company, as low as $199 per month

  • Compounded Semaglutide Tablets (daily oral tablet): according to the company, as low as $249 per month

Tirzepatide Options:

  • Compounded Injectable Tirzepatide (personalized injection): according to the company, as low as $299 per month

  • Compounded Tirzepatide Tablets (daily oral tablet): according to the company, as low as $299 per month

According to SkinnyRx, all medication ships with free overnight shipping directly to the patient's address. The company also states that dosage increases may result in higher monthly costs - always verify the latest pricing and your specific cost before enrolling.

Important Distinctions: SkinnyRx's website references brand-name medications like Ozempic, Wegovy, Zepbound, and Mounjaro. These are FDA-approved brand-name products manufactured by Novo Nordisk and Eli Lilly, respectively. The medications listed above with specific pricing are compounded versions - not the brand-name products.

Compounded semaglutide is not the same as Ozempic or Wegovy. Compounded tirzepatide is not the same as Mounjaro or Zepbound. Research on FDA-approved GLP-1 drugs is often cited in this category, but consumers should not assume compounded products are evaluated in the same way as FDA-approved finished medications. The compounding distinction affects regulatory status, manufacturing oversight, and how these medications have been studied.

Consumers should verify the latest pricing, eligibility, and formulation details directly on the company's current website before enrolling. For a broader look at how SkinnyRx's vendor positioning compares to other platforms in this space, read the full vendor evaluation here.

Check current SkinnyRx medication options and pricing

Platform Verification: What You Can Actually Check

This is the section that separates a verification article from a sales page. If you are evaluating whether SkinnyRx is a legitimate operation, here are the specific things you can look into - and the things you cannot confirm before enrolling.

What You Can Verify

Business Registration: SkinnyRx is operated by Lean Rx, Inc. The company lists a physical address in Sacramento, California (2108 N ST STE N, Sacramento, CA 95816), a customer service phone number (1-888-979-9580), and an email address ([email protected]). You can verify business registration through California's Secretary of State business search.

Published Terms and Privacy Policy: The company maintains publicly accessible Terms and Conditions (last updated January 17, 2025 as of the source material reviewed) and a Privacy Policy. The terms include a mandatory arbitration clause - meaning if you have a dispute, you generally must resolve it through individual arbitration rather than court proceedings or class actions. You have 30 days after accepting the terms to opt out by emailing support. Read this section before enrolling.

Customer Support Channels: The company lists phone support (1-888-979-9580), email support ([email protected]), and a mobile app (available on Apple App Store and Google Play). According to SkinnyRx, 24/7 live support is available.

Third-Party Reviews: SkinnyRx has a visible presence on Trustpilot, which may provide additional consumer feedback. Review platforms carry inherent self-selection bias - people who are very satisfied or very dissatisfied are more likely to leave reviews than those with neutral experiences - and third-party reviews should not be treated as clinical evidence or a substitute for your own due diligence.

Pharmacy Model: According to the company, their partner pharmacies are 503A facilities licensed by state boards of pharmacy. If you enroll and a specific pharmacy name is disclosed, you can verify that pharmacy's license through your state board of pharmacy.

Provider Licensing: SkinnyRx states that all providers are U.S.-based, licensed, and board-certified. After enrollment, you should be able to verify your specific provider's credentials through your state medical board.

Data Sharing Disclosure: Worth noting - the company's terms state that SkinnyRx uses customer information for third-party advertising purposes, including targeted advertising on platforms like Facebook and Google using hashed and de-identified data. You can opt out of marketing emails by following unsubscribe instructions or contacting support. Read the privacy policy before enrolling if data sharing concerns you.

What You Cannot Verify Independently Before Enrollment

  • The specific compounding pharmacies used - these are typically disclosed after enrollment, not publicly listed on the website

  • The company's claimed statistics, including a stated "98% SkinnyRx Program success rate" and "100,000+ prescriptions written" - these are company marketing claims without publicly detailed methodology. The term "success" is not defined in a way that allows independent evaluation

  • The company's referenced weight loss figures - the website has cited self-reported data from members using GLP-1 injections combined with diet and exercise. This is company-reported, self-reported data and should not be interpreted as a guaranteed or typical individual result. (See "Realistic Expectations" section below for full context.)

  • The specific credentials of individual providers prior to enrollment

  • How the company's operations have adapted to the current FDA enforcement environment following the end of shortage-based compounding discretion periods

A Note on Paid Testimonials

The SkinnyRx website features customer stories with before-and-after imagery. The site's own fine print discloses that these are paid testimonials, that customer results have not been independently verified, and that individual results may vary. This is worth factoring into your evaluation - paid testimonials represent marketing content, not independent endorsements. This article does not treat any testimonial as evidence of typical performance.

Eligibility, Safety, and What the Provider Evaluates

According to the website and provider protocols, SkinnyRx's GLP-1 program is intended for adults ages 18 to 64 with a BMI of 27 or higher. This is a service eligibility requirement - the actual clinical determination of whether medication is appropriate rests with the evaluating provider based on your individual health profile.

The Consultation Process: According to SkinnyRx, after completing a health intake quiz, a licensed clinician reviews your information. Depending on health needs, the evaluation may involve a video call or may result in a prescription directly within approximately 24 hours. The company states that you will not be charged if the provider determines you do not qualify.

Safety Considerations: GLP-1 medications - whether brand-name or compounded - carry known side effects. According to SkinnyRx's published provider guides, common mild side effects include nausea, constipation, bloating, burping, headache, and fatigue. Moderate effects may include stronger headaches, low blood sugar symptoms, or sleep difficulties. Severe effects requiring emergency medical attention include severe abdominal pain, yellowing of skin or eyes, swelling of face or throat, difficulty breathing, fainting, or vision changes.

These are prescription medications that affect metabolic processes. They are generally well tolerated when used as directed under medical supervision, but you should understand what to expect. The information above is a high-level overview, not a complete list of risks or precautions.

Pregnancy and Nursing: According to SkinnyRx, GLP-1 medications should not be used during pregnancy or breastfeeding. The company recommends discussing all medications with your provider if you are planning pregnancy.

Medication Storage: According to the company's provider protocols, injectable compounded semaglutide and tirzepatide should be stored in the refrigerator between 36°F and 46°F (2°C and 8°C) and never frozen. Oral and sublingual formulations may have different storage requirements - follow the specific instructions that accompany your prescription. Proper storage is essential for medication effectiveness and safety.

Alcohol: The company's provider guides advise limiting or avoiding alcohol during treatment, especially during dose adjustments, as it may worsen nausea, low blood sugar, or dehydration.

This is not a replacement for prescribed medical treatment for any other health condition. Always consult your physician if you have existing health conditions, take other medications, or have any questions before starting.

Cancellation and Refund Policy: Read This Carefully

The refund policy is an area where careful reading matters. According to SkinnyRx's published terms:

Before Prescription Review: You may cancel your order and receive a full refund at any time before a licensed provider completes your prescription review.

After Prescription and Fulfillment: Once the prescription has been completed and the fulfillment process has begun, according to the company, your order becomes non-refundable.

Ongoing Subscriptions: For subscription services, the company states you can cancel future months at any time. To avoid being charged for the next month, you must cancel before your next shipment is prepared. Renewal charges may process up to five days before the start of your next subscription period.

Partially Used Periods: According to the terms, SkinnyRx does not offer refunds for partially used subscription periods. However, the company states it may issue refunds on a case-by-case basis at its sole discretion.

Bundled Subscriptions: Per the company's terms, bundled subscriptions are non-refundable. Any medications already shipped as part of a subscription cannot be refunded.

Promotional Discount Reversal: If you cancel before the end of a promotional term, any discounts received may be reversed or proportionally adjusted, potentially reducing your refund amount.

In practical terms: Your primary window for a full refund is before the provider completes the prescription review. Once clinical review is complete and fulfillment begins, your financial commitment is largely locked in. Make sure you are comfortable with the subscription terms, cancellation timing, and refund limitations before completing the intake process.

Who SkinnyRx May Be Right For

SkinnyRx May Align Well With People Who:

Are comfortable with the compounded medication model: If you understand that compounded GLP-1 medications are not FDA-approved finished products, and you are comfortable with this regulatory distinction under the supervision of a licensed provider, SkinnyRx offers multiple compounded semaglutide and tirzepatide options with publicly listed pricing on its website.

Want multiple delivery format options: According to the company, SkinnyRx offers injectable, sublingual, and tablet formulations for both semaglutide and tirzepatide. Some people prefer oral options over injections, and having choices allows the evaluating provider to tailor the approach.

Prefer a fully online process: The platform operates entirely online with no in-person visits required, which may suit people with scheduling constraints or limited access to in-person weight management clinics.

Are looking for a cash-pay program: SkinnyRx does not accept commercial health insurance and is not enrolled in federal or state healthcare programs. If you are specifically seeking a cash-pay option and do not need insurance billing, this is how the platform operates.

Other Options May Be Preferable For People Who:

Want FDA-approved finished products: If having a medication that has been individually reviewed and approved by the FDA as a finished product is important to you, brand-name GLP-1 medications (Ozempic, Wegovy, Zepbound, Mounjaro) may be more appropriate - though availability and cost vary significantly.

Need insurance coverage: Because SkinnyRx operates on a cash-pay basis and does not bill insurance, people who need or prefer insurance-covered weight management programs should explore other options. The company states it accepts FSA/HSA cards - verify eligibility with your specific plan administrator.

Prefer in-person medical supervision: Some people want face-to-face medical oversight for prescription medications, particularly during initial dosing. If that describes you, a local provider or clinic may be a better fit.

Questions to Ask Yourself

Before choosing any GLP-1 telehealth platform, consider:

  • Am I comfortable with compounded medications that are not FDA-approved as finished products?

  • Do I understand the refund limitations once a prescription has been written?

  • Have I discussed GLP-1 medications with my primary care provider?

  • Is my BMI and health profile appropriate for these medications, or should I consult someone in person first?

  • Am I prepared for a monthly subscription commitment?

  • Have I read the terms of service, including the arbitration clause and data sharing provisions?

Your answers help determine which weight management approach and platform characteristics matter most for your specific situation.

View current SkinnyRx program options

Realistic Expectations: Context, Not Predictions

This section needs to be precise, because there is a meaningful distinction between what has been clinically studied and what SkinnyRx specifically offers.

Clinical research context: Large clinical trials of FDA-approved branded injectable semaglutide (conducted under controlled conditions) reported an average body weight reduction of approximately 14.9% from baseline to week 68, compared to 2.4% with placebo. This evidence relates to the branded, FDA-reviewed formulation studied in those trials and does not establish safety, effectiveness, or equivalence for compounded formulations, which are not FDA-approved finished products and may differ in concentration, excipients, and pharmacy-specific preparation.

Company-reported member data: The SkinnyRx website has referenced self-reported weight loss data from members using GLP-1 injections combined with diet and exercise. This is a company-reported, self-reported figure and should not be interpreted as a guaranteed or typical individual result. Self-reported data represents people who chose to report, which may skew toward those with more notable results. The figure references injectable GLP-1s combined with diet and exercise - not other formats or medication use alone. Consumers should verify the current version of this claim directly on the SkinnyRx website, as company statistics may be updated over time.

Individual response varies, and no article can predict personal outcomes. Factors include starting weight, baseline metabolic health, consistency of medication use, dietary habits, physical activity, genetic factors, medical history, and other individual variables. Some people respond strongly to GLP-1 medications, some respond gradually, and some may not respond as expected. If you do not see meaningful changes after 12 weeks, the company's own provider guides recommend reaching out to the clinical team for evaluation.

Weight loss typically slows after the first several months on GLP-1 medications. Stopping medication has been associated with weight regain - the SkinnyRx website itself notes this. These are important considerations for anyone evaluating the long-term commitment involved.

What This Article Does Not Confirm

This is a verification overview, not an endorsement. To be transparent about the limits of this analysis:

This article does not independently verify typical consumer outcomes. The self-reported member data referenced by the company has not been evaluated by this publication.

This article does not verify the internal methodology behind company-reported statistics, including the "98% success rate" or prescriptions-written figures.

This article does not identify every partner pharmacy. Specific pharmacy names are typically disclosed after enrollment, not on the public website.

This article does not determine clinical suitability for any individual reader. Only a licensed clinician, after reviewing your specific health information, can make that determination.

This article does not establish equivalence between compounded formulations and FDA-approved brand-name drugs. Those are distinct products under distinct regulatory frameworks.

This article does not make a determination about SkinnyRx's current regulatory compliance. The compounded GLP-1 regulatory landscape has changed materially since early 2025, and only the company and relevant regulatory bodies can speak to current compliance status.

What this article does provide is a framework for what you can check yourself and what questions to ask before enrolling in any compounded GLP-1 telehealth program.

Contact Information

For questions before or during the enrollment process, according to the company's website, SkinnyRx offers customer support through the following channels:

Phone: 1-888-979-9580

Email: [email protected]

Hours: According to the company, 24/7 live support is available

Address: 2108 N ST STE N, Sacramento, CA 95816

App: SkinnyRx mobile app available on Apple App Store and Google Play for order tracking and provider communication

View current SkinnyRx program details

Final Verdict: Is SkinnyRx Legit?

The Case for SkinnyRx

The platform has verifiable business infrastructure: a registered company (Lean Rx, Inc.) with a physical address in Sacramento, published terms and conditions, multiple customer contact channels including phone and email, and a mobile app for ongoing patient support. The platform uses a separation between the platform entity, prescribing clinicians, and dispensing pharmacies. The company offers both semaglutide and tirzepatide in multiple delivery formats with publicly listed pricing on its website. Third-party review platforms may provide additional consumer feedback, but they should not be treated as clinical evidence or as a substitute for reviewing the company's terms, disclosures, and provider process.

Considerations to Weigh

Compounded medications are not FDA-approved finished products. The FDA's shortage-based enforcement discretion periods for both semaglutide and tirzepatide compounding have ended, and the regulatory environment for compounded GLP-1 products continues to evolve. The company's most prominent marketing statistics - including the "98% success rate" and "100,000+ prescriptions written" - are company claims without publicly detailed methodology. The website features paid testimonials that have not been independently verified. The refund policy has meaningful restrictions once a prescription is written and fulfillment begins. The mandatory arbitration clause in the terms limits your legal options in the event of a dispute.

Important Note

The compounded GLP-1 telehealth industry has been under increased regulatory scrutiny. The FDA resolved both the semaglutide and tirzepatide shortages and ended temporary enforcement discretion periods for shortage-based compounding. Brand-name manufacturers have pursued legal actions related to compounded versions of their products. Consumers should review the most current FDA information and the most current status of any telehealth platform before proceeding. Only a licensed clinician can determine whether any GLP-1 medication - compounded or brand-name - is appropriate for your specific case.

See if you may qualify for the SkinnyRx program

Questions to Ask Before Paying for Any Compounded GLP-1 Program

Whether you are evaluating SkinnyRx or any other telehealth weight loss platform, these questions can help you make a more informed decision:

About the medication: Is this a compounded formulation or an FDA-approved brand-name product? If compounded, which pharmacy compounds it, and is that pharmacy licensed in your state? What is the specific active ingredient and dosage you would receive?

About the provider: Who is the prescribing clinician? Are they licensed in your state? Can you verify their credentials through your state medical board after enrollment? What happens if you need to reach your provider between scheduled check-ins?

About the costs: What is the total monthly cost at your starting dose, and how does it change as your dosage increases? Are there any additional fees for consultations, dosage adjustments, or shipping? What payment methods are accepted, and is the subscription auto-renewing?

About the terms: What is the refund policy before and after a prescription is written? Is there a mandatory arbitration clause? How much notice do you need to give before canceling to avoid being charged for the next cycle? What happens to promotional pricing if you cancel early?

About the regulatory context: How has the platform adapted since the FDA resolved the semaglutide and tirzepatide shortages? Does the company publicly address the current compounding regulatory environment?

No platform should make you feel rushed past these questions. If one does, that is information too.

What to Read in the Terms Before You Submit Payment

Most people skip the terms of service. For a compounded GLP-1 telehealth subscription, that is a mistake. Here are the specific sections worth reading before you commit:

The refund and cancellation section. Understand exactly when the refund window closes. For SkinnyRx, according to the company's terms, the window closes once a provider completes the prescription review and fulfillment begins. Know the difference between canceling a subscription (stopping future charges) and requesting a refund (getting money back for a current or past charge).

The arbitration clause. Many telehealth platforms - SkinnyRx included - require disputes to be resolved through individual arbitration rather than court. This means you generally waive the right to a jury trial or class action participation. Some terms offer a limited opt-out window. For SkinnyRx, according to the terms, that window is 30 days after accepting the agreement.

The data-sharing provisions. Review what information the company collects, how it is used, and whether it is shared with third parties for advertising purposes. SkinnyRx's terms, for example, disclose the use of customer data for targeted advertising on platforms like Facebook and Google.

The company's role versus the provider's role. Make sure you understand that the telehealth platform is not your healthcare provider. The prescribing clinician is a separate, independent entity. If something goes wrong medically, your recourse is with the provider, not the platform company - and that distinction matters if a dispute arises.

Reading these sections takes about fifteen minutes. For a recurring prescription commitment, that is time well spent.

Frequently Asked Questions

Is SkinnyRx the same as getting Ozempic or Wegovy?

No. According to SkinnyRx, the platform primarily offers compounded versions of semaglutide and tirzepatide. Compounded GLP-1 products are marketed using semaglutide or tirzepatide formulations, but they are distinct from FDA-approved finished brand-name drugs like Ozempic, Wegovy, Zepbound, or Mounjaro. Compounded formulations are not individually reviewed or approved by the FDA as finished products and have not undergone the same clinical testing or premarket review.

Does SkinnyRx accept insurance?

According to the company's terms, SkinnyRx and its affiliated medical practices do not accept commercial health insurance plans and are not enrolled in federal or state healthcare programs including Medicare and Medicaid. The company operates on a cash-pay basis. The website states that FSA and HSA cards are accepted - verify eligibility with your plan administrator before purchasing.

What happens if I do not qualify for medication?

According to the company's FAQ, you will not be charged if the provider determines you are not eligible. Payment is processed only after you complete the pre-qualification quiz and choose your medication. If the provider determines you do not qualify, the company states that a full refund will be issued within 24 to 48 hours.

How does cancellation work?

According to the company's terms, you can cancel by contacting the Customer Help Center, calling 1-888-979-9580, or managing your subscription through your online account. Cancellation takes effect at the end of the current subscription period. To avoid being charged for the next month, cancel at least five days before the renewal processing date.

What should consumers understand about compounded GLP-1 products?

Compounded GLP-1 products are marketed using semaglutide or tirzepatide formulations, but they are distinct from FDA-approved finished brand-name drugs and are not individually evaluated by the FDA for safety, effectiveness, or quality. The regulatory landscape for compounded GLP-1 products has changed materially since early 2025, with the FDA resolving both semaglutide and tirzepatide shortages and ending temporary enforcement discretion periods. Long-term safety should be assessed by your prescribing provider. Consumers should review the most current FDA guidance before starting any compounded GLP-1 medication.

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are not guarantees and are not a substitute for an individualized medical evaluation. GLP-1 medications available through SkinnyRx are compounded prescription medications that require evaluation by a licensed clinician. The information provided here does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. GLP-1 medications are not a substitute for prescribed medical treatment for any other health condition. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any new prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance and approval.

Compounded Medication Notice: GLP-1 medications available through SkinnyRx are compounded prescription medications prepared by licensed pharmacies based on individual prescriptions. Compounded medications are not reviewed or approved by the FDA as finished products. They are prepared using active ingredients under the direction of a prescribing clinician. Compounded formulations are not equivalent to FDA-approved brand-name medications and have not undergone the same clinical testing or premarket review.

Results May Vary: Individual results will vary based on factors including age, starting weight, baseline metabolic health, dietary habits, physical activity level, consistency of medication use, genetic factors, current medications, and other individual variables. Company-referenced weight loss data is self-reported and should not be interpreted as a typical or guaranteed outcome. Clinical research cited in this category pertains to FDA-approved branded medications studied under controlled conditions and does not establish expected results for compounded formulations.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on publicly available information from SkinnyRx's official website, published terms, and provider guides.

Pricing Disclaimer: All prices, medication options, and promotional offers mentioned were accurate based on publicly available information at the time of publication (March 2026) but are subject to change without notice. Dosage increases may result in higher costs. Always verify current pricing, eligibility, and terms on the official SkinnyRx website before enrolling.

Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with SkinnyRx and their healthcare provider before making decisions.

Insurance Coverage Note: According to SkinnyRx's terms, the company and its affiliated medical practices do not accept commercial health insurance plans and are not enrolled in federal or state healthcare programs. The platform operates on a cash-pay basis. The company states that FSA and HSA cards are accepted; verify eligibility with your specific plan administrator before purchasing.

SOURCE: SkinnyRx

Source: SkinnyRx

Share:


Tags: compounded GLP-1, compounded semaglutide, compounded tirzepatide, GLP-1, GLP-1 telehealth, semaglutide review, SkinnyRx, telehealth weight loss, tirzepatide review, weight loss medication


SkinnyRx Online GLP-1 Treatments Customer Support
Press Contact SkinnyRx